Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DHA-PQ for Seasonal Malaria Prevention in Children
NCT00941785Phase 3Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Jul 2009
- Primary completion
- Dec 2009
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of dihydroartemisinin and piperaquine in malaria, sponsored by London School of Hygiene & Tropical Medicine. Primary endpoint: Efficacy against clinical malaria. Started Jul 2009; status: completed.
02
Drugs
dihydroartemisininpiperaquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT00941785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00941785.